Europe Pharmaceutical Contract Sales Organizations Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Pharmaceutical Contract Sales Organizations Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Market Opportunities

5.2.1 Rising Use of Telemedicine and Remote Detailing

5.3 Future Trends

5.3.1 Expansion in Emerging Markets

5.4 Impact of Drivers and Restraints

6. Europe Pharmaceutical Contract Sales Organizations Market Regional Analysis

6.1 Europe Pharmaceutical Contract Sales Organizations Market Overview

6.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue 2020-2030 (US$ Million)

6.3 Europe Pharmaceutical Contract Sales Organizations Market Forecast Analysis

7. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Services

7.1 Commercial Services

7.1.1 Overview
7.1.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Non-Commercial Services

7.2.1 Overview
7.2.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Modules

8.1 Syndicated Modules

8.1.1 Overview
8.1.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Dedicated Modules

8.2.1 Overview
8.2.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Therapeutic Area

9.1 Cardiovascular Disorders

9.1.1 Overview
9.1.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Oncology

9.2.1 Overview
9.2.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Metabolic Disorders

9.3.1 Overview
9.3.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Neurology

9.4.1 Overview
9.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Orthopedic Diseases

9.5.1 Overview
9.5.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

9.6 Infectious Diseases

9.6.1 Overview
9.6.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market – Europe Analysis

10.1 Europe

10.1.1 Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.1.2 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.1.3 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

10.1.1.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.2.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.2.3 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

10.1.1.3 France: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.3.2 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.3.3 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

10.1.1.4 Russia: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.4.2 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.4.3 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

10.1.1.5 Italy: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.5.2 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.5.3 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

10.1.1.6 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
10.1.1.6.2 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
10.1.1.6.3 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Pharmaceutical Contract Sales Organizations Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Aenova Holding GmbH

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 IQVIA Holdings Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 MaBico SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Pfizer Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Syneos Health Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights